Recent News

• 11.09.2026 - NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth
• 10.27.2026 - NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026
• 10.15.2026 - NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
• 09.29.2026 - NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
• 09.16.2026 - NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
• 09.16.2026 - NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
• 08.11.2026 - NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth
• 08.04.2026 - NeurAxis Expands Payer Coverage with New Policies
• 07.28.2026 - NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026
• 04.22.2026 - NeurAxis Expands Payer Coverage with Four New Medical Policies

Recent Filings

• 11.09.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.14.2026 - 8-K Current report
• 10.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2026 - 3 Initial statement of beneficial ownership of securities
• 08.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2026 - 8-K Current report